Schizophrenia, monosymptomatic hypochondriacal psychosis, paranoid psychosis
The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
Central nervous system
LSCMMG is adopting the local decision made prior to April 2013
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria